Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 1/2011

01.02.2011

Chronic Migraine: Epidemiology and Disease Burden

verfasst von: Aubrey N. Manack, Dawn C. Buse, Richard B. Lipton

Erschienen in: Current Pain and Headache Reports | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Chronic migraine is a common and disabling complication of migraine with a population prevalence of about 2%. Emerging evidence suggests that episodic migraine and chronic migraine differ not only in degree, but also in kind. Compared with patients with episodic migraine, those with chronic migraine have worse socioeconomic status, reduced health-related quality of life, increased headache-related burden (including impairment in occupational, social, and family functioning), and greater psychiatric and medical comorbidities. Each year, approximately 2.5% of patients with episodic migraine develop new-onset chronic migraine (ie, chronification). Understanding the natural disease course, improving treatment and management, and preventing the onset could reduce the enormous individual and societal burden of chronic migraine, and thus, have become important goals of headache research. This review provides a summary of the history of nomenclature and diagnostic criteria, as well as recent studies focusing on the epidemiology, natural history, and burden of chronic migraine.
Literatur
1.
Haut SR, Bigal ME, Lipton RB: Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006, 5:148–157.PubMedCrossRef
2.
Manack A, Turkel C, Silberstein S: The evolution of chronic migraine: classification and nomenclature. Headache 2009, 49:1206–1213.PubMedCrossRef
3.
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26:742–746.PubMedCrossRef
4.
Olesen J: International Classification of Headache Disorders, Second Edition (ICHD-2): current status and future revisions. Cephalalgia 2006, 26:1409–1410.PubMedCrossRef
5.
Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ: Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007, 27:814–823.PubMedCrossRef
6.
Scher AI, Stewart WF, Liberman J, Lipton RB: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.PubMedCrossRef
7.
Castillo J, Muñoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196.PubMedCrossRef
8.
Lantéri-Minet M, Auray JP, El Hasnaoui A, Dartigues JF, Duru G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF: Prevalence and description of chronic daily headache in the general population in France. Pain 2003, 102:143–149.PubMedCrossRef
9.
Wiendels NJ, Knuistingh NA, Rosendaal FR, Spinhoven P, Zitman FG, Assendelft WJ, Ferrari MD: Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 2006, 26:1434–1442.PubMedCrossRef
10.
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB: Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008, 48:1157–1168.PubMedCrossRef
11.
•• Buse DC, Manack A, Serrano D, Turkel C, Lipton RB: Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010, 81:428–432. This article provides new evidence regarding the sociodemographic and comorbidity profile associated with chronic migraine. Anxiety, depression, nonheadache chronic pain disorders, respiratory disorders including asthma, bronchitis and chronic obstructive pulmonary disease, and cardiac risk factors including hypertension, diabetes, high cholesterol, and obesity all were significantly more likely to be reported by patients with chronic migraine than by those with episodic migraine.
12.
Wang SJ, Fuh JL, Lu SR, Liu CY, Hsu LC, Wang PN, Liu HC: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000, 54:314–319.PubMed
13.
Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001, 21:980–986.PubMedCrossRef
14.
Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ: Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008, 28:484–495.PubMedCrossRef
15.
Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, on behalf of the PREEMPT Chronic Migraine Study Group: OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010, 50:921–963.PubMedCrossRef
16.
Mathew NT, Reuveni U, Perez F: Transformed or evolutive migraine. Headache 1987, 27:102–106.PubMedCrossRef
17.
Silberstein SD, Lipton RB, Solomon S, Mathew NT: Classification of daily and near-daily headache: Proposed revisions to the IHS criteria. Headache 1994, 34:1–7.CrossRef
18.
Silberstein SD, Lipton RB, Sliwinski M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871–875.PubMed
19.
The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.
20.
Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB: Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 2004, 44:684–691.PubMedCrossRef
21.
Bigal ME, Sheftell FD, Rapoport AM, Lipton RB, Tepper SJ: Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002, 22:432–438.PubMedCrossRef
22.
Olesen J: The future of headache classification and classification research. Cephalalgia 2009, 29:1240–1241.PubMedCrossRef
23.
Zeeberg P, Olesen J, Jensen R: Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria. Cephalalgia 2009, 29:214–220.PubMedCrossRef
24.
Fuh JL, Wang SJ, Lu SR, Juang KD: Does medication overuse headache represent a behavior of dependence? Pain 2005, 119:49–55.PubMedCrossRef
25.
Lipton RB, Bigal ME: Chronic daily headache: is analgesic overuse a cause or a consequence? Neurology 2003, 61:154–155.PubMed
26.
Manzoni GC, Lambru G, Torelli P: Chronically evolving headaches: classification and terminology. Neurol Sci 2006, 27(Suppl 2):S164-S167.PubMedCrossRef
27.
•• Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, Lipton R: Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010, 30:599–609. This article provides an overview of chronic migraine prevalence estimates and explores global differences with a relevant discussion on the various diagnostic criteria for chronic migraine.
28.
Katsarava Z, Manack A, Yoon M-S, Obermann M, Becker H, Dommes P, Turkel C, Lipton RB, Diener HC: Chronic migraine: classification and comparisons. Neurology 2010, In press.
29.
Straube A, Pfaffenrath V, Ladwig KH, Meisinger C, Hoffmann W, Fendrich K, Vennemann M, Berger K: Prevalence of chronic migraine and medication overuse headache in Germany-the German DMKG headache study. Cephalalgia 2010, 30:207–213.PubMedCrossRef
30.
•• Katsarava Z, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M, Jensen R, Stovner LJ, Steiner TJ: Primary headache disorders in the Republic of Georgia: Prevalence and risk factors. Neurology 2009, 73:1796–1803. This study utilized a community-based, door-to-door survey design to estimate the prevalence of primary headache disorders within a developing region and determined that rates were comparable to European Union and United States estimates. This study also substantiated the unmet medical needs for those suffering from headache.
31.
• da Silva A, Jr., Costa EC, Gomes JB, Leite FM, Gomez RS, Vasconcelos LP, Krymchantowski A, Moreira P, Teixeira AL: Chronic Headache and Comorbibities: A Two-Phase, Population-Based, Cross-Sectional Study. Headache 2010, Epub ahead of print. There is limited data on the prevalence and disease course of chronic daily headache in South America. This article concludes that the prevalence of chronic daily headache in rural area of Brazil is similar to previously published data in South America, and that psychiatric conditions often are comorbid.
32.
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004, 62:788–790.PubMed
33.
Dahlöf CG, Johansson M, Casserstedt S, Motallebzadeh T: The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study. Headache 2009, 49:1144–1152.PubMedCrossRef
34.
Bigal M: Migraine chronification--concept and risk factors. Discov Med 2009, 8:145–150.PubMed
35.
Ashina S, Lyngberg A, Jensen R: Headache characteristics and chronification of migraine and tension-type headache: A population-based study. Cephalalgia 2010, 30:943–952.PubMed
36.
Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KM: Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 4-22-2003, 60:1308–1312.
37.
•• Blumenfeld AM, Varon SF, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB: Disability, HRQOL and Resource Use Among Chronic and Episodic Migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia 2010, doi:10.​1177/​0333102410381145​. This study is the only multicountry, international study of migraine epidemiology, impact, and burden. The study utilized a web-based survey with items that parallel the United States AMPP study questionnaires. Results of this article compare persons with episodic migraine and chronic migraine on headache features, headache-related disability, health-related quality of life, health care resource utilization, and medical and psychiatric comorbidities across nine countries.
38.
Ashina S, Buse DC, Manack AN, Serrano D, Maizels M, Turkel C, Lipton RB. Depression: a risk factor for migraine chronification: results from the American Migraine Prevalence and Prevention (AMPP) Study. Neurology 74(Suppl 2):A113, 2010. Presented at the Annual Meeting of the American Academy of Neurology, April 13, 2010.
39.
Bigal ME, Lipton RB: Modifiable risk factors for migraine progression. Headache 2006, 46:1334–1343.PubMedCrossRef
40.
Lipton RB: Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology 2009, 72:S3-S7.PubMedCrossRef
41.
Lipton RB, Bigal ME: Looking to the future: research designs for study of headache disease progression. Headache 2008, 48:58–66.PubMedCrossRef
42.
Manack A, Buse DC, Serrano D, Turkel CC, Lipton RB: Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 2010, In press.
43.
Couch JR, Lipton RB, Stewart WF, Scher AI: Head or neck injury increases the risk of chronic daily headache: a population-based study. Neurology 2007, 69:1169–1177.PubMedCrossRef
44.
Lipton RB, Chu MK: Conceptualizing the relationship between chronic migraine and episodic migraine. Expert Rev Neurother 2009, 9:1451–1454.PubMedCrossRef
45.
Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D, Lipton RB: Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008, 70:1525–1533.PubMedCrossRef
46.
• Yalug I, Selekler M, Erdogan A, Kutlu A, Dundar G, Ankarali H, Aker T: Correlations between alexithymia and pain severity, depression, and anxiety among patients with chronic and episodic migraine. Psychiatry Clin Neurosci 2010, 64:231–238. This article explored the unclear but hypothesized correlation between alexithymia and the severity of pain, depression, and anxiety among patients with migraine and concluded that depression and anxiety were significantly correlated with alexithymia in both episodic and chronic migraine. Additionally, there was a positive association between depression, anxiety, and alexithymia in both subsets of patients with migraine.
47.
Bigal ME, Serrano D, Reed M, Lipton RB: Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008, 71:559–566.PubMedCrossRef
48.
Wang SJ, Fuh JL, Lu SR, Juang KD: Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 2001, 89:285–292.PubMedCrossRef
49.
•• Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, Reed M, Lipton RB: Economic burden of transformed migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study. Headache 2009, 49:498–508. This article highlights the economic burden that chronic migraine imposes on society in the United States.
50.
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646–657.PubMedCrossRef
51.
Stewart WF, Lipton RB, Dowson AJ, Sawyer J: Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001, 56:S20-S28.PubMed
52.
Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB: Employment and Work Impact of Chronic Migraine and Episodic Migraine. J Occup Environ Med 2010, 52:8–14.PubMedCrossRef
Metadaten
Titel
Chronic Migraine: Epidemiology and Disease Burden
verfasst von
Aubrey N. Manack
Dawn C. Buse
Richard B. Lipton
Publikationsdatum
01.02.2011
Verlag
Current Science Inc.
Erschienen in
Current Pain and Headache Reports / Ausgabe 1/2011
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-010-0157-z

Weitere Artikel der Ausgabe 1/2011

Current Pain and Headache Reports 1/2011 Zur Ausgabe

ReviewPaper

Complementary and Alternative Medicine for Pain: An Evidence-based Review

ReviewPaper

Updated Perspectives on Neurogenic Thoracic Outlet Syndrome

ReviewPaper

Update on Hemicrania Continua

Clinical Trial Report

OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine

Clinical Trial Report

Fibromyalgia Tender Points at Examination Sites Specified by the American College of Rheumatology Criteria Are Almost Universally Myofascial Trigger Points

ReviewPaper

New Daily Persistent Headache: Controversy in the Diagnostic Criteria

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren